Plus therapeutics presents data from preclinical study of rhenium-186 nanoliposome in leptomeningeal metastases and plans for further evaluation with upcoming phase 1 clinical trial

Positive data to support fda ind application for the clinical evaluation of rhenium-186 nanoliposome ( 186 rnl) targeted radiotherapy for patients with leptomeningeal metastases (lm)
pstv Ratings Summary
pstv Quant Ranking